1. Home
  2. MBINL vs SCLXW Comparison

MBINL vs SCLXW Comparison

Compare MBINL & SCLXW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBINL
  • SCLXW
  • Stock Information
  • Founded
  • MBINL N/A
  • SCLXW N/A
  • Country
  • MBINL
  • SCLXW United States
  • Employees
  • MBINL 663
  • SCLXW 115
  • Industry
  • MBINL
  • SCLXW Biotechnology: Pharmaceutical Preparations
  • Sector
  • MBINL
  • SCLXW Health Care
  • Exchange
  • MBINL NYSE
  • SCLXW Nasdaq
  • Market Cap
  • MBINL N/A
  • SCLXW N/A
  • IPO Year
  • MBINL N/A
  • SCLXW N/A
  • Fundamental
  • Price
  • MBINL $23.20
  • SCLXW $0.09
  • Analyst Decision
  • MBINL
  • SCLXW
  • Analyst Count
  • MBINL 0
  • SCLXW 0
  • Target Price
  • MBINL N/A
  • SCLXW N/A
  • AVG Volume (30 Days)
  • MBINL N/A
  • SCLXW 4.0K
  • Earning Date
  • MBINL N/A
  • SCLXW 03-07-2025
  • Dividend Yield
  • MBINL N/A
  • SCLXW N/A
  • EPS Growth
  • MBINL N/A
  • SCLXW N/A
  • EPS
  • MBINL N/A
  • SCLXW N/A
  • Revenue
  • MBINL N/A
  • SCLXW $55,152,000.00
  • Revenue This Year
  • MBINL N/A
  • SCLXW N/A
  • Revenue Next Year
  • MBINL N/A
  • SCLXW N/A
  • P/E Ratio
  • MBINL N/A
  • SCLXW N/A
  • Revenue Growth
  • MBINL N/A
  • SCLXW 22.02
  • 52 Week Low
  • MBINL N/A
  • SCLXW $0.18
  • 52 Week High
  • MBINL N/A
  • SCLXW $0.18
  • Technical
  • Relative Strength Index (RSI)
  • MBINL N/A
  • SCLXW N/A
  • Support Level
  • MBINL N/A
  • SCLXW N/A
  • Resistance Level
  • MBINL N/A
  • SCLXW N/A
  • Average True Range (ATR)
  • MBINL 0.00
  • SCLXW 0.00
  • MACD
  • MBINL 0.00
  • SCLXW 0.00
  • Stochastic Oscillator
  • MBINL 0.00
  • SCLXW 0.00

About MBINL MERCHANTS BANCORP DEP SHS REPSTG 1/40TH INT PFD SER E

Merchants Bancorp is a United States based bank holding company. It operates multiple lines of business focusing on FHA (Federal Housing Administration) multi-family housing and healthcare facility financing and servicing, retail and correspondent residential mortgage banking, and traditional community banking. The business segments of the company are: Multi-family Mortgage Banking which originates and services government-sponsored mortgages for multi-family and healthcare facilities; Mortgage Warehousing segment which funds agency-eligible residential loans as well as commercial loans to nondepository financial institutions; and the Banking segment, which generates maximum revenue, and provides various financial products and services to consumers and businesses.

About SCLXW Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Share on Social Networks: